BioMedica Diagnostics is a proudly Canadian company focusing on thrombosis & haemostasis diagnostic solutions for human and animal health. BioMedica offers a comprehensive line of diagnostic and research products, recently strengthened through an acquisition of specialty coagulation products and technologies. In the BioMedica line-up, partners will find high-quality kits, controls, reagents, calibrators, antibodies and substrates that are designed for clinical use in routine and specialty coagulation and are also widely used in research and industry environments. BioMedica products are available for sale directly to laboratories and can also be purchased worldwide through a network of elite distributors.
Many products are Health Canada Registered, FDA 510(k) cleared and/or CE marked. In addition to clinical partners, BioMedica also works with industry partners to OEM or customize products that are manufactured to a partner’s custom requested specifications, available in a final packaged format or as bulk intermediary product, ready for further manufacture.
94 Wentworth Road
Windsor, Nova Scotia
Brian Jeffers, President & CEO
- BioMedica Diagnostics Inc a new business approach for a new future
- BioMedica Diagnostics receives support from Government of Canada
- BIOMEDICA DIAGNOSTICS: BioMedica Diagnostics has acquired the specialty coagulation business and product line from Sekisui Diagnostics
- BioPort News: Meet Honorary Conference Chair Dr. Abdullah Kirumira
- Biotech, the People Behind the Science
- How BioMedica Reached a 50/50 Gender Balance Without Trying
- News Release: BioMedica Diagnostics Acquires Sekisui Diagnostics